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INTRODUCTION
MicroRNAs (miRNAs) are 20-25 nucleotide long noncoding RNAs that have been found in a wide variety of organisms and shown to exert essential roles by regulating the stability and translation of target messenger RNAs (mRNAs) (1) (2) (3) (4) . Interestingly, most miRNAs show tissue-specific and developmentally regulated expression (5) (6) (7) (8) . To investigate the role played by miRNAs during development, the establishment of techniques allowing the detection/monitoring of miRNA expression during cell fate change in vivo is crucial (9) . To detect miRNAs in tissues microscopically, two ingenious approaches have been used: (i) in situ hybridization using locked nucleic acid (LNA)-modified DNA oligonucleotide probes, which detect the presence of miRNAs irrespective of their potential activity (8) and (ii) the expression or administration of target mRNAs (sensors), which detect miRNAs via their degradation-triggering activity toward the sensor (10) (11) (12) .
Although both approaches are powerful, certain limitations remain. Thus, in situ hybridization using LNA probes requires tissue fixation, which prevents the monitoring of miRNA appearance/disappearance in a given cell lineage during cell fate change. While this limitation could potentially be overcome by in vivo expression of a sensor mRNA encoding a fluorescent protein, the latter approach has typically involved the generation of transgenic animals (10, 11) . Moreover, in the sensor approach, a lack of signal is interpreted as being indicative of the presence of a miRNA, which calls for some means of verification that the sensor mRNA is actually being transcribed in the cell lacking sensor protein. Overcoming these limitations, we report here a relatively simple and reliable system that allows the detection of miRNAs with cellular resolution in vivo without the need to generate transgenic animals.
MATERIALS AND METHODS

DFRS Plasmids
Details concerning the construction of the dual-fluorescent green fluorescent protein (GFP)-reporter/monomeric red fluorescent protein (mRFP)-sensor (DFRS) plasmids used are provided in the supplementary materials available online at www.BioTechniques.com.
Zebrafish Embryo Injection
All embryos were obtained from the zebrafish AB wild-type line. Single blastomeres of 2-to 8-cell stage embryos were injected with approximately 500 pL phosphate-buffered saline (PBS) containing, as the standard concentration, 0.1 μg/μL purified DFRS plasmid. In some experiments, a higher concentration (0.5 μg/μL) was used. Embryos were maintained in E3 medium and manipulated by standard methods (13) .
Mouse Embryo Electroporation
In utero electroporation of mouse embryos was performed as described (14) , except that the topology of the embryos was determined using illumination and a dissecting microscope rather than ultrasound microscopy. Pregnant mice 13 days postcoitum were anesthetized with isofluorane vapor and their uteri exposed. Using a glass capillary, 1-3 μL PBS containing 3-5 μg/μL DFRS plasmid were injected through the uterine wall into the lumen of the telencephalic vesicles or released in proximity of the ectoderm of the embryo. Immediately after injection, 6 square electrical pulses of 30 V, 50 ms each at 1-s intervals were delivered through platinum electrodes (2 mm diameter) using a BTX ® -ECM ® 830 electroporator (Harvard Apparatus, Holliston, MA, USA). The orientation of the electric field was used to direct the uptake of the plasmid to specific regions of the developing brain or ectoderm. After electroporation, the uterus was relocated into the peritoneal cavity, and the abdomen was sutured. Mice were sacrificed either 24 or 72
Single-cell detection of microRNAs in developing vertebrate embryos after acute administration of a dual-fluorescence reporter/sensor plasmid Short Technical Reports h after in utero electroporation, and the embryos were collected for further analyses. Ex utero electroporation of DFRS plasmids into telencephalic vesicles of E10 mouse embryos followed by 24 h of whole-embryo culture was performed as described previously (15) .
In Situ Hybridization on Cryosections Using LNA-Modified Oligonucleotides
Whole-mount E11 and E14 mouse embryos were fixed overnight at 4°C in 4% paraformaldehyde in 120 mM phosphate buffer, pH 7.4, equilibrated in 30% sucrose in PBS, and embedded in Tissue-Tek ® , and 10-μm cryosections were prepared. In situ hybridization was performed according to standard protocols with the following modifications. LNA-modified DNA oligonucleotides (Exiqon A/S, Vedbaek, Denmark) were labeled with digoxygenin (DIG)-ddUTP using the DIG oligonucleotide 3′ end labeling kit (Roche Diagnostic GmbH, Mannheim, Germany) according to manufacturer's instructions. Prehybridized cryosections were incubated overnight at 51°C (miR-9) or 59°C (miR-124a) in hybridization buffer containing 200 pmol/mL of DIG-labeled LNA-oligonucleotide. Following incubation with alkaline phosphatase-conjugated anti-DIG antibody at 4°C overnight, staining with 5-bromo-4-chloro-3-indoxyl phosphate/nitro blue tetrazolium (BCIP/NBT; Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) was done at 37°C for 2 h and then either at 4°C for 1-2 days or at room temperature for 6-12 h. Images were acquired with a standard upright microscope (Olympus ® Optical, Europe GmbH, Hamburg, Germany).
Fluorescence Microscopy
Anesthetized zebrafish, at the indicated stages of development, and whole-mount mouse embryos or dissected brains (unfixed) were imaged using a Model SZX12 dissecting microscope equipped with epifluorescence (Olympus, Hamburg, Germany). Cryosections of brains, fixed as above, were permeabilized with 0.3% Triton ® X-100 in PBS and quenched with 10 mM NH 4 Cl prior to analysis using a Model BX61 fluorescence microscope (Olympus) or an Axiovert 200 laser-scanning confocal microscope (Carl Zeiss GmbH, Jena, Germany). Images were acquired and processed using the IPlab software version 3.5.1 (Scanalytics, Rockville, MD, USA) or the Zeiss LSM Image Examiner software version 3.2.0.70 (Carl Zeiss GmbH).
RESULTS AND DISCUSSION
Dual-Fluorescence GFP-Reporter/ mRFP-Sensor Plasmid
Our system is based on the acute administration of a DFRS plasmid for a specific miRNA into the organism of interest. In our DFRS plasmids, both GFP and mRFP are under the control of identical constitutive promoters [Supplementary Figure S1 , simian virus 40 (SV40)]. The GFP-reporter was used to identify the cells actually expressing the plasmid, given that the sensor-based strategy relies on the silencing of a transcript. The mRFP-sensor contained a 3′ untranslated region (UTR) with a tandem cassette (10, 11) 
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(Supplementary Figure S1 , referred to as mutated DFRS plasmid). Second, we used a DFRS plasmid that contained a tandem cassette with an arbitrary sequence that was not complementary to any known miRNA (Supplementary Figure S1 , referred to as DFRS control plasmid).
Visualization of miR-1 Appearance in Skeletal Muscle Fibers of Developing Zebrafish Using a DFRS Plasmid
We initially explored the use of DFRS plasmids for miRNA detection using the zebrafish as a model system. Specifically, we tested a DFRS plasmid for miR-1, which has been shown to be expressed in developing skeletal muscle of zebrafish (8) . The DFRS miR-1 plasmid was injected into one blastomere of 2-to 8-cell stage embryos, and embryos were allowed to develop for up to 9 days, resulting in mosaic transgene expression. After 8 hours postfertilization (hpf) (approximately 75%-80% of epiboly; i.e., before the onset of skeletal muscle development) (16), both GFP-reporter and mRFP-sensor fluorescence were observed, being colocalized in most, if not all, cells (Figure 1, A-C) . This indicated that miR-1 was not yet expressed at this early stage of zebrafish development. At a later stage (i.e., after 33 hpf) when skeletal muscle has been formed (16) , most of the GFPexpressing fibers did not show mRFPsensor fluorescence (Figure 1 , D-F, arrows); these were identified as muscle fibers by whole-mount immunostaining 72 hpf using an anti-myosin heavy chain antibody (Supplementary Figure  S2) . After 9 days postfertilization (dpf), essentially all GFP-expressing muscle fibers lacked mRFP-sensor fluorescence (Supplementary Figure  S3) . In contrast to the results obtained with the DFRS miR-1 plasmid, both GFP-reporter and mRFP-sensor fluorescence were observed in muscle fibers after blastomere injection of the mutated DFRS miR-1 plasmid 33 hpf (Figure 1, G-I, triangles) and of the DFRS control plasmid 33 hpf (not shown) and 9 dpf (Supplementary Figure S3) . We therefore conclude that the lack of mRFP-sensor fluorescence in DFRS miR-1 plasmid-expressing muscle fibers at 33 hpf and thereafter indicated the presence of active miR-1, (which prevented further synthesis of mRFP), consistent with previous microarray and in situ hybridization data (8) . On a more general note, our observations demonstrate that the use of a DFRS plasmid, by allowing the comparison between GFP-reporter and mRFP-sensor fluorescence, provides certainty in interpreting the lack of sensor fluorescence as being indicative of the presence of a miRNA (rather than the lack of transcription of the sensor gene). 
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To explore whether a DFRS plasmid can be used to reveal the appearance of a miRNA in a given cell, we compared, after blastomere injection of DFRS miR-1 plasmid, the intensity of mRFPsensor fluorescence in the same muscle fibers at two time points during earlier stages of skeletal muscle development, 17 and 22 hpf. Remarkably, some muscle fibers showing both GFP and mRFP fluorescence at 17 hpf ( Figure  1 , J and K, open arrows) completely lost mRFP-sensor ( Figure 1N , open arrow), but not GFP-reporter ( Figure  1M , open arrow), fluorescence just 5 h later and other muscle fibers that still showed mRFP-sensor fluorescence at 22 hpf ( Figure 1N , triangles) had lost it at 43 hpf (data not shown). In contrast, cells lacking miR-1 expression, such as those of the notochord (8), maintained both GFP-reporter and mRFP-sensor expression throughout (Figure 1 , J, K, M, and N, asterisks and data not shown). These observations show that the DFRS miR-1 plasmid can be used to visualize the appearance of miR-1 activity in skeletal muscle during zebrafish development, which implies that the half-life of mRFP under the present conditions was sufficiently short so as not to obscure the appearance of the miRNA activity.
It could be argued that the disappearance of mRFP fluorescence from 17 to 22 hpf in some muscle fibers ( Figure 1, K and N, open arrows) but not others ( Figure 1 , K and N, triangles) may reflect a lower copy number of DFRS miR-1 plasmid in the former than the latter muscle fibers. To address this issue, we compared GFPreporter and mRFP-sensor fluorescence in various muscle fibers at 22 hpf after blastomere injection of a 5-fold higher DFRS miR-1 plasmid concentration (0.5 μg/μL) than the standard one (0.1 μg/μL). While with 0.5 μg/μL DFRS miR-1 plasmid, muscle fibers showed, on average, an increase in GFPreporter fluorescence (Supplementary Figure S4D) as compared with 0.1 μg/μL DFRS miR-1 plasmid (Supplementary Figure S4A) , we did not note an increase in mRFP-sensor fluorescence at the higher DFRS miR-1 plasmid concentration (Supplementary Figure S4, B and E) . Moreover, at either DFRS miR-1 plasmid concen- Figure S4 , C and F, arrowheads and arrows) reflected a variation in miR-1 activity, which is consistent with the development of distinct subtypes of muscle fibers (16) . This issue could be investigated further by combining, similar to the approach shown in the Supplementary Figure S2 , the analysis of miR-1 expression using the DFRS plasmid with immunocytochemistry using antibodies that discriminate between muscle fiber subtypes.
Single-Cell Detection of miRNAs in Mosaic Mouse Embryos after Acute Tissue Targeting of DFRS Plasmids
In contrast to zebrafish and flies, the generation of mammalian transgenic animals is much more labor-intensive. To establish a system allowing the monitoring of miRNA dynamics in defined cell lineages during mammalian embryonic development, we explored the use of DFRS plasmids in conjunction with a combination of methods previously used to achieve acute expression of transgenes and RNA interference in developing mouse 
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Control embryos. This combination consists of the topical release of nucleic acids in the proximity of a specific tissue of a mouse embryo developing either in culture or in utero and their delivery into this tissue by directed electroporation. This combination of methods has been successfully applied, in particular, to the developing mouse brain (14, 15) . Given that Northern blot and microarray analyses and cDNA cloning have previously shown miR-9 to be expressed in the developing and adult rodent brain (5-7,17) , we explored the use of a DFRS miR-9 plasmid (Supplementary Figure S1 ) to detect this miRNA in the developing brain. As controls, we used (i) a DFRS miR-9 plasmid in which three nucleotides in each miR-9 complementary sequence were mutated to prevent miR-9 binding; (ii) a DFRS control plasmid, the tandem cassette of which was not complementary to any known mouse miRNA; and (iii) a DFRS plasmid that contained, instead of the tandem cassette complementary to miR-9, a tandem cassette complementary to miR-1 (Supplementary Figure S1) , which is known to be expressed in the developing cardiac and skeletal muscles, but not brain, of the mouse embryo (5, 11, 18) .
The DFRS plasmids were injected into the lumen of the telencephalic vesicles of embryonic day 13 (E13) mouse embryos in utero and electroporated into the left telencephalic neuroepithelium (Figure 2 , A-J). After in utero development for 24 h, analysis of GFP-reporter and mRFP-sensor fluorescence showed that in the case of the mutated DFRS miR-9 plasmid, both fluorescent proteins were expressed in the E14 telencephalon (Figure 2 , B and C), being colocalized in the same neuroepithelial cells (Figure 2 , D and E). Similar results were obtained with the DFRS control plasmid or the DFRS miR-1 plasmid (data not shown), the latter finding being consistent with the lack of miR-1 expression in the developing brain (5, 11, 18) . In contrast, in the case of the DFRS miR-9 plasmid, only GFP-reporter (Figure 2 , G and I), but not mRFP-sensor (Figure 2 , H and J), fluorescence was detected, indicating the presence of this miRNA in E14 telencephalic neuroepithelial cells.
To corroborate the presence of miR-9 in the neuroepithelium, we performed in situ hybridization with an LNA probe (8) on cryosections through the head of E14 mice ( Figure 2N ), which yield superior cellular resolution as compared with whole-mount preparations (19) . Indeed, miR-9 was found to be abundantly expressed in the dorsal telencephalon of E14 mouse embryos ( Figure 2N ), being present in both the neuronal progenitors in the ventricular zone ( Figure 2N, vz) (i.e., neuroepithelial cells) and the postmitotic neurons in the cortical plate ( Figure 2N , cp), but being absent in the developing ectoderm ( Figure 2N , ec, arrowhead). As a further control, when the DFRS miR-9 plasmid was electroporated into the E13 ectoderm (rather than brain) followed by 24 h of in utero development ( Figure 2 , K-M), both GFPreporter and mRFP-sensor fluorescence were observed, being colocalized in the same cells (Figure 2 , L and M). This showed that the DFRS miR-9 plasmid was functional in terms of GFP-reporter plus mRFP-sensor expression and demonstrated the absence of miR-9 in the E14 ectoderm, consistent with the results of in situ hybridization ( Figure  2N, ec, arrowhead) .
In another set of experiments, the DFRS miR-9 plasmid was electroporated into the E13 mouse diencephalic neuroepithelium followed by 3 days of in utero development. In this case, we detected GFP-reporter, but not mRFP-sensor, fluorescence not only in neuroepithelial cells but also in cortical neurons (Supplementary Figure S5) , consistent with the presence of miR-9 in cortical neurons ( Figure 2N, cp) .
miR-124a Is Expressed in Neurons and Neuronal Progenitors
We extended the DFRS approach to another miRNA, miR-124a, which is thought to be expressed specifically in neurons (20) . During the development of the mouse central nervous system, newborn neurons prior to their migration to the neuronal layers coexist with the neuronal progenitors in the ventricular zone. We therefore modified the DFRS plasmid by adding a plasma membrane localization signal to the GFP-reporter (pmGFP; see the supplementary materials for details) in order to distinguish newborn neurons in the ventricular zone from neuroepithelial cells by outlining the distinct shape of these cell types. Indeed, when the DFRS control plasmid was electroporated into the E10 mouse telencephalic neuroepithelium ex utero followed by 24 h of whole-embryo culture, both the neuroepithelial cells in the ventricular zone (Figure 3 , A-C, vz) and the neurons born in the ventricular zone (identified by the nonradial orientation of their cell body; Figure 3 , A-C, vz, arrowheads) and present in the neuronal layer (Figure 3 , A-C, nl) showed pmGFP-reporter and mRFP-sensor expression. Surprisingly, however, upon electroporation of the DFRS miR-124a plasmid, essentially all cells [i.e., not only the neurons born in the ventricular zone ( Figure  3E , vz, arrowhead) and present in the neuronal layer ( Figure 3E, nl) , but also the neuroepithelial cells ( Figure 3E,  vz) , which constitute the vast majority of the cells in the ventricular zone] lacked mRFP-sensor fluorescence, although there was robust expression of the DFRS miR-124a plasmid in these cells as revealed by pmGFP-reporter fluorescence ( Figure 3D ). The same results were obtained upon electroporation of the DFRS miR-124a plasmid into the E13 mouse telencephalic neuroepithelium followed by 24 h of in utero development, and mutation of three nucleotides of each miR124a target sequence (Supplementary Figure S1 ) was sufficient to prevent mRFP-sensor silencing (data not shown). These observations indicate that, contrary to the prevailing notion (20) , miR-124a is expressed not only in postmitotic neurons but also in their progenitors, the neuroepithelial cells. These unexpected results on miR-124a were corroborated by in situ hybridization with a miR-124a LNA probe (8) on cryosections of E11 mouse brain, which confirmed the presence of a low level of miR-124a in the ventricular zone ( Figure 3F , vz) (in addition to the known massive expression in the neuronal layer; Figure 3F , nl). The lowlevel in situ hybridization signal in the ventricular zone was specific as no such signal was detected in the ectoderm ( Figure 3F, asterisk) , which is known to Short Technical Reports lack miR-124a expression. Thus, on a more general note, our findings demonstrate that the acute administration of a DFRS plasmid is a valid approach to gain novel information about the expression of a given miRNA.
In conclusion, the present experimental approach of acutely administering a DFRS plasmid for a specific miRNA offers a convenient method to detect these important posttranscriptional regulators with singlecell resolution and to monitor their dynamics in vivo. Our approach, which presumably is applicable to a wide variety of species (including those for which transgenic lines have not been established), circumvents the need to generate transgenic organisms, which is much more labor-intensive for mice (11) than for flies (10) . Moreover, the topical administration of DFRS plasmids, followed by their directed electroporation (15, 21) 
